IRA A GREENSTEIN
CIK 1228161 · President · last filed 2017-01-19
IRA A GREENSTEIN is a President who has filed 42 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider had shares withheld for taxes covering $18.2K of GNE on Jan 19, 2017. Across all open-market trades the lifetime net is +$228.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.95M
6
42
$228.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GNE | President | 100,985 | $14.32 | $1.45M | $0 | 13 | 2017-01-19 |
| NeuBase Therapeutics, Inc. (OHRP) Delisted | Director | 331,051 | — | — | $8.4K | 6 | 2016-01-26 |
| DSS | Director | 12 | $0.54 | $7 | $0 | 7 | 2015-01-13 |
| IDT | President | 51,552 | $67.88 | $3.50M | $0 | 1 | 2011-04-06 |
| IDT CORP (IDT.C) Delisted | President | 51,557 | — | — | $205.3K | 7 | 2011-01-04 |
| DSS, INC. (DMC) Delisted | Director | 10,000 | — | — | $15.0K | 3 | 2009-04-20 |
Recent Filings
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-01-19 | GNE | Tax (F) | −3,108 | -$18.2K | EDGAR |
| 2016-07-20 | — | Grant (A) | — | $0 | |
| 2016-06-17 | GNE | Mixed | — | $0 | EDGAR |
| 2016-06-17 | GNE | Mixed | — | $0 | EDGAR |
| 2016-01-26 | NeuBase Therapeutics, Inc. (OHRP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-14 | GNE | Tax (F) | −3,096 | -$28.8K | EDGAR |
| 2016-01-11 | NeuBase Therapeutics, Inc. (OHRP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-08-06 | — | Grant (A) | — | $0 | |
| 2015-06-15 | GNE | Mixed | — | $0 | EDGAR |
| 2015-03-12 | NeuBase Therapeutics, Inc. (OHRP) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.